硼中子捕获疗法市场：依产品类型、应用、硼化合物、最终用户和地区划分

预计到 2025 年，硼中子捕获疗法 (BNCT) 市值为 1.941 亿美元，预计到 2032 年将达到 6.676 亿美元，2025 年至 2032 年的复合年增长率为 19.2%。

硼中子捕获疗法 (BNCT) 是一种创新且标靶性强的放射治疗方法，已成为治疗多种癌症（尤其是脑瘤、头颈癌和黑色素瘤）的一种极具前景的治疗方法。这种创新治疗方法利用硼-10与热中子之间独特的核反应，选择性地破坏癌细胞，同时最大限度地减少对健康组织的损伤。全球硼中子捕获疗法市场涵盖了从中子源、硼化合物、治疗计划系统到旨在提供精准治疗性介入的专用医疗设施等一系列完整的生态系统。

此治疗方法的基本原理是使硼-10载体优先聚集在癌细胞中。随后，中子照射会诱发局部核反应，产生高能量粒子，从而选择性地清除细胞范围内的癌细胞。随着全球医疗体係日益重视个人化医疗和标靶癌症治疗，硼中子捕获疗法（BNCT）已引起肿瘤学家、医疗设备製造商、製药公司和研究机构的广泛关注。中子源技术的进步、硼输送化合物的改进、更先进的治疗计划软体以及更广泛的临床应用，都推动了该疗法的市场成长。

市场动态

全球硼中子捕获疗法（BNCT）市场受多种强烈因素驱动，显示其在现代肿瘤学中的重要性日益凸显。主要市场驱动因素源自于全球癌症负担的不断加重，这主要归因于脑瘤、头颈癌以及难以用传统疗法有效治疗的抗药性恶性肿瘤发生率的上升。医疗服务提供者和患者日益寻求疗效更佳、副作用更小的标靶治疗方案，这使得BNCT成为极具吸引力的解决方案。中子源开发技术的进步，包括无需核子反应炉的加速器中子源，显着提高了治疗的可及性和安全性。癌症研究投入的不断增加，以及鼓励创新癌症疗法的政府支持政策和法规结构，共同为市场创造了有利环境。

然而，市场面临许多限制因素，可能阻碍其广泛应用和发展。硼中子捕获疗法（BNCT）设施所需的极高初始资本投入（包括专用基础设施、中子源和先进的治疗计划系统）对医疗机构构成了巨大的财务障碍。能够实施BNCT治疗的训练有素的医务人员短缺、复杂的治疗通讯协定以及漫长的患者准备过程，再加上其他因素，限制了市场渗透率。硼化合物核准相关的监管挑战以及中子发生器严格的安全要求也构成了额外的障碍。儘管有这些限制因素，但将临床应用拓展到传统适应症之外，例如肝转移瘤、復发性胶质母细胞瘤和儿童癌症，仍蕴藏着巨大的市场机会。医疗设备製造商、製药公司和研究机构之间的策略联盟将有助于技术开发和市场扩张。随着医疗基础设施的意识提升的提高，新兴市场展现出尚未开发的成长潜力。同时，正在进行的临床试验持续证明BNCT对多种癌症类型的有效性，并有望彻底改变标靶放射治疗方法。

本报告的主要特点

• 本报告对全球硼中子捕获疗法市场进行了详细分析，并给出了预测期（2025-2032 年）的市场规模和复合年增长率，以 2024 年为基准年。
• 它还重点介绍了各个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
• 它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的关键见解。
• 全球硼中子捕获疗法市场的主要企业将根据以下参数进行分析，例如公司概况、产品系列、主要亮点、财务表现和策略。
• 本报告提供的见解将使负责人和企业经营团队能够就未来的产品发布、合作关係、市场扩张和行销策略做出明智的决策。
• 《全球硼中子捕获疗法市场》报告面向该行业的各类相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过各种策略矩阵来分析全球硼中子捕获疗法市场，从而更轻鬆地做出决策。

目录

第一章 分析目标和先决条件

• 分析目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要

第三章：市场动态、监管与趋势分析

• 市场动态
• 司机
• 抑制因素
• 机会
• 影响分析
• 重大进展
• 监管情景
• 产品发布/核准
• PEST分析
• 波特五力分析
• 企业合併情景
• 产业趋势

4. 全球硼中子捕获疗法市场（依产品类型划分）（2020-2032 年）

• 介绍
• 硬体/设备
• 解决方案
• 药物

5. 全球硼中子捕获疗法市场按应用领域划分（2020-2032 年）

• 介绍
• 原发性癌症治疗（头颈癌、復发性胶质母细胞瘤等）
• 辅助性治疗（术后治疗，与其他治疗方法合併使用）
• 研究用途（临床前研究、临床试验）

6. 全球硼中子捕获疗法市场（依硼化合物划分）（2020-2032 年）

• 介绍
• 硼苯丙胺酸（BPA）
• 硼酸钠（BSH）
• 其他硼化合物

7. 全球硼中子捕获疗法市场（依最终用户划分）（2020-2032 年）

• 介绍
• 医院
• 研究所
• 专科诊所
• 製药公司
• 学术机构

8. 全球硼中子捕获疗法市场（按地区划分）（2020-2032 年）

• 介绍
• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 亚太其他地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中非

第九章 竞争情势

• Neutron Therapeutics
• Sumitomo Heavy Industries
• TAE Life Sciences
• RaySearch Laboratories
• Stella Pharma Corporation
• International Particle Therapy
• Neuboron Medtech
• Advanced Oncotherapy plc
• Mitsubishi Heavy Industries
• Mevion Medical Systems
• SHINE Technologies
• Casbnct
• Aviko Radiopharmaceuticals
• China Boron（Xiamen）Medical Equipment Co., Ltd.
• SHI-ATEX Co., Ltd.

第十章 分析师建议

• 《命运之轮》
• 分析师观点
• Coherent Opportunity Map (COM)

第十一章 参考文献与分析方法

• 参考
• 分析方法
• 关于 Coherent Market Insights

Boron Neutron Capture Therapy Market is estimated to be valued at USD 194.1 Mn in 2025 and is expected to reach USD 667.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 19.2% from 2025 to 2032.

Boron Neutron Capture Therapy (BNCT) represents a revolutionary targeted radiotherapy approach that has emerged as a promising treatment modality for various cancers, particularly brain tumors, head and neck cancers, and melanoma. This innovative therapy leverages the unique nuclear reaction between boron-10 and thermal neutrons to selectively destroy malignant cells while minimizing damage to healthy tissue. The global boron neutron capture therapy market encompasses a comprehensive ecosystem of neutron sources, boron compounds, treatment planning systems, and specialized medical facilities designed to deliver precise therapeutic interventions.

The therapy's fundamental principle involves the preferential accumulation of boron-10 carriers in tumor cells, followed by neutron irradiation that triggers localized nuclear reactions, producing high-energy particles that selectively eliminate cancer cells within a cellular range. As healthcare systems worldwide increasingly prioritize personalized medicine and targeted cancer treatments, BNCT has gained significant attention from oncologists, medical device manufacturers, pharmaceutical companies, and research institutions. The market's growth trajectory is supported by advancing neutron source technologies, improved boron delivery compounds, enhanced treatment planning software, and expanding clinical applications.

Market Dynamics

The global boron neutron capture therapy market is propelled by several compelling drivers that underscore its growing significance in modern oncology practice. The primary market driver stems from the escalating global cancer burden, with increasing incidence rates of brain tumors, head and neck cancers, and treatment-resistant malignancies that conventional therapies struggle to address effectively. Healthcare providers and patients increasingly seek targeted treatment alternatives that offer superior therapeutic outcomes while minimizing adverse effects, positioning BNCT as an attractive solution. Technological advancements in neutron source development, including accelerator-based neutron sources that eliminate the need for nuclear reactors, significantly enhance treatment accessibility and safety profiles. Growing investments in cancer research, coupled with supportive government initiatives and regulatory frameworks encouraging innovative cancer therapies, create favorable market conditions.

However, the market faces substantial restraints that could impede widespread adoption and growth. The exceptionally high initial capital investment required for BNCT facilities, including specialized infrastructure, neutron sources, and advanced treatment planning systems, presents significant financial barriers for healthcare institutions. Limited availability of trained medical professionals capable of administering BNCT treatments, combined with complex treatment protocols and lengthy patient preparation processes, restricts market penetration. Regulatory challenges associated with boron compound approval and stringent safety requirements for neutron-generating equipment create additional hurdles. Despite these constraints, significant market opportunities emerge from expanding clinical applications beyond traditional indications, including potential treatments for liver metastases, recurrent glioblastoma, and pediatric cancers. Strategic partnerships between medical device manufacturers, pharmaceutical companies, and research institutions facilitate technology development and market expansion. Emerging markets present untapped growth potential as healthcare infrastructure develops and cancer treatment awareness increases, while ongoing clinical trials continue to demonstrate BNCT's efficacy across diverse cancer types, potentially revolutionizing targeted radiotherapy approaches.

Key Features of the Study

• This report provides in-depth analysis of the global boron neutron capture therapy market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global boron neutron capture therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Neutron Therapeutics, Sumitomo Heavy Industries, TAE Life Sciences, RaySearch Laboratories, Stella Pharma Corporation, International Particle Therapy, Neuboron Medtech, Advanced Oncotherapy plc, Mitsubishi Heavy Industries, Mevion Medical Systems, SHINE Technologies, Casbnct, Aviko Radiopharmaceuticals, China Boron (Xiamen) Medical Equipment Co., Ltd., and SHI-ATEX Co., Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global boron neutron capture therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global boron neutron capture therapy market

Market Segmentation

• Product Type Insights (Revenue, USD Mn, 2020 - 2032)
  • Hardware/Equipment
  • Neutron sources
  • Beam-shaping devices
  • Dosimetry systems
  • Patient Positioning System (Couch)
  • Solutions
  • Radiation protection agents
  • Companion diagnostics
  • Drugs
  • Boron-10 enriched compounds
  • Radiosensitizers
• Application Insights (Revenue, USD Mn, 2020 - 2032)
  • Primary Cancer Treatment (Head and Neck Cancer, Recurrent Glioblastoma, etc,)
  • Adjuvant Therapy (Post-surgical treatment, Combination with other therapies)
  • Research Applications (Preclinical studies, Clinical trials)
• Boron Compound Insights (Revenue, USD Mn, 2020 - 2032)
  • Boronophenylalanine (BPA)
  • Sodium Borocaptate (BSH)
  • Other Boron Compounds
• End User Insights (Revenue, USD Mn, 2020 - 2032)
  • Hospitals
  • Research Institutes
  • Specialty Clinics
  • Pharmaceutical Companies
  • Academic Institutions
• Regional Insights (Revenue, USD Mn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Neutron Therapeutics
  • Sumitomo Heavy Industries
  • TAE Life Sciences
  • RaySearch Laboratories
  • Stella Pharma Corporation
  • International Particle Therapy
  • Neuboron Medtech
  • Advanced Oncotherapy plc
  • Mitsubishi Heavy Industries
  • Mevion Medical Systems
  • SHINE Technologies
  • Casbnct
  • Aviko Radiopharmaceuticals
  • China Boron (Xiamen) Medical Equipment Co., Ltd.
  • SHI-ATEX Co., Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Boron Neutron Capture Therapy Market, By Product Type
  • Global Boron Neutron Capture Therapy Market, By Application
  • Global Boron Neutron Capture Therapy Market, By Boron Compound
  • Global Boron Neutron Capture Therapy Market, By End User
  • Global Boron Neutron Capture Therapy Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Boron Neutron Capture Therapy Market, By Product Type, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Hardware/Equipment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Neutron sources
    • Beam-shaping devices
    • Dosimetry systems
    • Patient Positioning System (Couch)
• Solutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Radiation protection agents
    • Companion diagnostics
• Drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Boron-10 enriched compounds
    • Radiosensitizers

5. Global Boron Neutron Capture Therapy Market, By Application, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Primary Cancer Treatment (Head and Neck Cancer, Recurrent Glioblastoma, etc.,)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Adjuvant Therapy (Post-surgical treatment, Combination with other therapies)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Research Applications (Preclinical studies, Clinical trials)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Boron Neutron Capture Therapy Market, By Boron Compound, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Boronophenylalanine (BPA)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Sodium Borocaptate (BSH)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Other Boron Compounds
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Boron Neutron Capture Therapy Market, By End User, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Pharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Academic Institutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Boron Neutron Capture Therapy Market, By Region, 2020 - 2032, Value (USD Mn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Boron Compound, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Boron Compound, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Boron Compound, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Boron Compound, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Boron Compound, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Boron Compound, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Neutron Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sumitomo Heavy Industries
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• TAE Life Sciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• RaySearch Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Stella Pharma Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• International Particle Therapy
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Neuboron Medtech
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Advanced Oncotherapy plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Mitsubishi Heavy Industries
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Mevion Medical Systems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• SHINE Technologies
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Casbnct
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Aviko Radiopharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• China Boron (Xiamen) Medical Equipment Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• SHI-ATEX Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About Us